» Articles » PMID: 22298923

Michigan Clostridium Difficile Hospital Discharges: Frequency, Mortality, and Charges, 2002-2008

Overview
Publisher Sage Publications
Specialty Public Health
Date 2012 Feb 3
PMID 22298923
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Clostridium difficile (C. difficile) causes an intestinal bacterial infection of increasing importance in Michigan residents and health-care facilities. The specific burden and health-care costs of C. difficile infection (CDI) were previously unknown. We evaluated the frequency, mortality, and health-care charges of CDI from Michigan hospital discharge data.

Methods: The Michigan Department of Community Health purchased discharge data from all Michigan acute care hospitals from the Michigan Health and Hospital Association. We extracted all hospital discharges from 2002 through 2008 containing the International Classification of Diseases, Ninth Revision code for intestinal infection due to C. difficile. Discharges were stratified by principle diagnosis and comorbidity level. Total hospitalization charges were standardized to the 2008 U.S. dollar.

Results: From 2002 through 2008, 68,686 hospital discharges with CDI occurred. The annual rate increased from 463.1 to 1096.5 CDI discharges per 100,000 discharges. CDI discharge rates were substantially higher among the elderly, females, and black people. Of all CDI discharges, 5,924 (8.6%) patients died. The mean total health-care charge for the time period was $67,149, and the annual mean increased 35% from 2002 to 2008. Hospital charges varied significantly by race/ethnicity and age. People with Medicaid insurance accrued the highest charges.

Conclusion: Across Michigan, the CDI burden is growing substantially and affecting vulnerable populations. Surveillance utilizing hospital discharge data can illuminate trends and inform intervention targets. To reduce disease and health-care charges, increased prevention and infection-control efforts should be directed toward high-risk populations, such as the elderly.

Citing Articles

Racial Differences in Plasma Microbial Translocation and Plasma Microbiome, Implications in Systemic Lupus Erythematosus Disease Pathogenesis.

Wen X, Ogunrinde E, Wan Z, Cunningham M, Gilkeson G, Jiang W ACR Open Rheumatol. 2024; 6(6):365-374.

PMID: 38563441 PMC: 11168915. DOI: 10.1002/acr2.11664.


Economic Burden of Clostridioides difficile Infection in European Countries.

Reigadas E, Vazquez-Cuesta S, Bouza E Adv Exp Med Biol. 2024; 1435:1-12.

PMID: 38175468 DOI: 10.1007/978-3-031-42108-2_1.


Global burden of infections: a systematic review and meta-analysis.

Balsells E, Shi T, Leese C, Lyell I, Burrows J, Wiuff C J Glob Health. 2019; 9(1):010407.

PMID: 30603078 PMC: 6304170. DOI: 10.7189/jogh.09.010407.


Cost of hospital management of Clostridium difficile infection in United States-a meta-analysis and modelling study.

Zhang S, Palazuelos-Munoz S, Balsells E, Nair H, Chit A, Kyaw M BMC Infect Dis. 2016; 16(1):447.

PMID: 27562241 PMC: 5000548. DOI: 10.1186/s12879-016-1786-6.


Recurrent Clostridium difficile infection: From colonization to cure.

Shields K, Araujo-Castillo R, Theethira T, Alonso C, Kelly C Anaerobe. 2015; 34:59-73.

PMID: 25930686 PMC: 4492812. DOI: 10.1016/j.anaerobe.2015.04.012.


References
1.
Oughton M, Loo V, Dendukuri N, Fenn S, Libman M . Hand hygiene with soap and water is superior to alcohol rub and antiseptic wipes for removal of Clostridium difficile. Infect Control Hosp Epidemiol. 2009; 30(10):939-44. DOI: 10.1086/605322. View

2.
Pepin J, Valiquette L, Alary M, Villemure P, Pelletier A, Forget K . Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ. 2004; 171(5):466-72. PMC: 514643. DOI: 10.1503/cmaj.1041104. View

3.
Dubberke E, Reske K, McDonald L, Fraser V . ICD-9 codes and surveillance for Clostridium difficile-associated disease. Emerg Infect Dis. 2006; 12(10):1576-9. PMC: 3290935. DOI: 10.3201/eid1210.060016. View

4.
Dubberke E, Reske K, Olsen M, McDonald L, Fraser V . Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients. Clin Infect Dis. 2008; 46(4):497-504. DOI: 10.1086/526530. View

5.
Zilberberg M, Shorr A, Kollef M . Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005. Emerg Infect Dis. 2008; 14(6):929-31. PMC: 2600276. DOI: 10.3201/eid1406.071447. View